Funding
Who is funding the trial?
The trial is funded by ViiV Healthcare (Study 207742).
The MRC Clinical Trials Unit at UCL receives core support from the UK Medical Research Council (grant number MC_UU_12023/26).
Who is sponsoring the trial?
Fondazione Penta ETS (Penta) is the trial sponsor and has delegated responsibility for the management of the D3 trial to the MRC CTU at UCL.